Finance

Lists
ADXN:NASDAQ
Addex Therapeutics Ltd - ADR
3,22 USD
+1,21%
(+0,039) 1D
9-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADXN...
Open
3,09 USD
High
3,25 USD
Low
3,09 USD
Mkt. cap
6,34 млн
Avg. vol.
30,86 миң
Volume
4,41 миң
52-wk high
11,97 USD
52-wk low
2,56 USD
EPS
-8,41 USD
Beta
1,52
Shares outstanding
1,82 млн
No. of employees
3
Open
3,09 USD
High
3,25 USD
Low
3,09 USD
Mkt. cap
6,34 млн
Avg. vol.
30,86 миң
Volume
4,41 миң
52-wk high
11,97 USD
52-wk low
2,56 USD
EPS
-8,41 USD
Beta
1,52
Shares outstanding
1,82 млн
No. of employees
3
News stories
From web sources and news partners
About Addex Therapeutics Ltd - ADR
CEO-
Employees3
Founded2002
Headquarters-
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
49,60 миң
15,83 миң
7,69 миң
9,95 миң
Cost of goods sold
228,32 миң
52,81 миң
36,13 миң
37,99 миң
Cost of revenue
228,32 миң
52,81 миң
36,13 миң
37,99 миң
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
517,45 миң
742,28 миң
451,39 миң
617,31 миң
Operating expense
517,45 миң
742,28 миң
451,39 миң
617,31 миң
Total operating expenses
745,78 миң
795,09 миң
487,52 миң
655,30 миң
Operating income
-696,18 миң
-779,26 миң
-479,83 миң
-645,35 миң
Other non operating income
-
-
-
3,38 миң
EBT including unusual items
-1,58 млн
-1,83 млн
-1,71 млн
-1,74 млн
EBT excluding unusual items
-1,58 млн
-1,83 млн
-1,71 млн
-1,74 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,58 млн
-1,84 млн
-1,71 млн
-1,74 млн
Net profit margin
-3 179,90%
-11 604,47%
-22 256,39%
-17 537,99%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-472,00
-575,00
-956,00
-1,18 миң
Net interest expenses
-472,00
-575,00
-956,00
-1,18 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-696,07 миң
-779,16 миң
-479,72 миң
-645,25 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору